mobiflex and pirprofen

mobiflex has been researched along with pirprofen* in 1 studies

Trials

1 trial(s) available for mobiflex and pirprofen

Article	Year
[Clinical experiences with tenoxicam. Preliminary results of a multicenter study]. Recenti progressi in medicina, 1991, Volume: 82, Issue:4 Preliminary data concerning the efficacy and tolerability of tenoxicam in a large, multicenter Italian study are presented. In many centres 625 patients (31% of the total) have been evaluated: 283 patients with osteoarthrosis and 342 with extra-articular rheumatism completed the study. Efficacy of tenoxicam (20 mg/die) was stated as equivalent or superior to reference drugs (diclofenac 100 R, piroxicam 20 mg). Tolerability profile has been generally good; tenoxicam, in particular showed the lowest incidence of side effects (7.4%). Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis; Phenylpropionates; Piroxicam; Rheumatic Diseases	1991

Article

Year

[Clinical experiences with tenoxicam. Preliminary results of a multicenter study].

Recenti progressi in medicina, 1991, Volume: 82, Issue:4

Preliminary data concerning the efficacy and tolerability of tenoxicam in a large, multicenter Italian study are presented. In many centres 625 patients (31% of the total) have been evaluated: 283 patients with osteoarthrosis and 342 with extra-articular rheumatism completed the study. Efficacy of tenoxicam (20 mg/die) was stated as equivalent or superior to reference drugs (diclofenac 100 R, piroxicam 20 mg). Tolerability profile has been generally good; tenoxicam, in particular showed the lowest incidence of side effects (7.4%).

Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis; Phenylpropionates; Piroxicam; Rheumatic Diseases

1991